In today’s session McKesson Corporation (MCK) registered an unusually high (210) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the February, 2017 call, expecting serious MCK increase. With 210 contracts traded and 1014 open interest for the Feb, 17 contract, it seems this is a quite bullish bet. The option with symbol: MCK170217C00160000 closed last at: $1.6 or 22% down. About 376,389 shares traded hands. McKesson Corporation (NYSE:MCK) has declined 15.07% since April 28, 2016 and is downtrending. It has underperformed by 21.00% the S&P500.
Analysts await McKesson Corporation (NYSE:MCK) to report earnings on January, 25. They expect $2.96 earnings per share, down 6.92% or $0.22 from last year’s $3.18 per share. MCK’s profit will be $681.30 million for 12.13 P/E if the $2.96 EPS becomes a reality. After $2.94 actual earnings per share reported by McKesson Corporation for the previous quarter, Wall Street now forecasts 0.68% EPS growth.
McKesson Corporation (NYSE:MCK) Ratings Coverage
Out of 17 analysts covering McKesson Corporation (NYSE:MCK), 7 rate it a “Buy”, 1 “Sell”, while 9 “Hold”. This means 41% are positive. $275 is the highest target while $147 is the lowest. The $203.25 average target is 41.55% above today’s ($143.59) stock price. McKesson Corporation has been the topic of 42 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The rating was maintained by FBR Capital with “Outperform” on Thursday, July 30. The rating was downgraded by Standpoint Research on Tuesday, April 26 to “Hold”. The firm has “Mkt Perform” rating given on Tuesday, January 12 by Raymond James. Deutsche Bank maintained the stock with “Buy” rating in Tuesday, January 12 report. The rating was maintained by Mizuho with “Buy” on Monday, September 21. The rating was initiated by UBS on Thursday, October 6 with “Neutral”. On Friday, July 31 the stock rating was maintained by S&P Research with “Buy”. RBC Capital Markets maintained McKesson Corporation (NYSE:MCK) rating on Tuesday, January 12. RBC Capital Markets has “Outperform” rating and $190.0 price target. The rating was downgraded by Standpoint Research to “Hold” on Friday, November 11. Mizuho maintained it with “Buy” rating and $210 target price in Tuesday, October 27 report.
According to Zacks Investment Research, “McKesson Corporation, the world’s largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.”
Insitutional Activity: The institutional sentiment increased to 1.06 in 2016 Q2. Its up 0.23, from 0.83 in 2016Q1. The ratio is positive, as 79 funds sold all McKesson Corporation shares owned while 353 reduced positions. 88 funds bought stakes while 269 increased positions. They now own 186.66 million shares or 6.92% less from 200.54 million shares in 2016Q1.
Blb&B Advsr Limited Liability accumulated 2,000 shares or 0.07% of the stock. Suncoast Equity Management holds 4.01% or 68,824 shares in its portfolio. Dnb Asset Mgmt As reported 50,562 shares or 0% of all its holdings. Kistler, a Alabama-based fund reported 382 shares. Utd Capital Finance Advisers Ltd Com has 62,309 shares for 0.12% of their US portfolio. Godsey & Gibb Assocs holds 1.86% of its portfolio in McKesson Corporation (NYSE:MCK) for 54,859 shares. Burney holds 1.14% of its portfolio in McKesson Corporation (NYSE:MCK) for 85,226 shares. Centurylink Inv Management Company holds 0.04% of its portfolio in McKesson Corporation (NYSE:MCK) for 541 shares. Meiji Yasuda Life Ins has 0.38% invested in the company for 12,778 shares. Moreover, Psagot Invest House has 0.19% invested in McKesson Corporation (NYSE:MCK) for 24,150 shares. Pinnacle Fincl Ptnrs Incorporated has 1,110 shares for 0.05% of their US portfolio. Gerstein Fisher owns 16,541 shares or 0.4% of their US portfolio. Ellington Management Gp Ltd Liability Corp has invested 0.39% of its portfolio in McKesson Corporation (NYSE:MCK). Allen Management Ltd Liability Corporation last reported 1.62% of its portfolio in the stock. Bokf Na last reported 0.05% of its portfolio in the stock.
Insider Transactions: Since August 1, 2016, the stock had 1 insider purchase, and 7 selling transactions for $37.72 million net activity. HAMMERGREN JOHN H also sold $18.17M worth of McKesson Corporation (NYSE:MCK) on Monday, September 12. $136,351 worth of McKesson Corporation (NYSE:MCK) was bought by SALKA SUSAN R. The insider BUDD WAYNE A sold $414,920. $288,570 worth of McKesson Corporation (NYSE:MCK) was sold by Lampert Erin M on Monday, October 3. KNOWLES MARIE L/CA had sold 915 shares worth $176,348 on Monday, August 1. JACOBS M CHRISTINE also sold $177,312 worth of McKesson Corporation (NYSE:MCK) on Monday, August 22.
McKesson Corporation is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The company has a market cap of $33.05 billion. The Firm operates through two divisions: McKesson Distribution Solutions and Technology Solutions. It has a 16.12 P/E ratio. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
MCK Company Profile
McKesson Corporation (McKesson), incorporated on July 7, 1994, is a pharmaceutical distribution services and information technology company. The Firm delivers an offering of pharmaceuticals and medical supplies. The Firm operates through two divisions: McKesson Distribution Solutions and McKesson Technology Solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.